Ocugen

Ocugen’s Revolutionary Gene Therapy Targets Geographic Atrophy: A Shift in Ophthalmology on the Horizon

MALVERN, PA — Ophthalmology is on the crest of a wave; a paradigm shift heralded by Ocugen, Inc (NASDAQ: OCGN) may be imminent. The Pennsylvania-based biopharmaceutical firm recently crossed a …

Ocugen’s Revolutionary Gene Therapy Targets Geographic Atrophy: A Shift in Ophthalmology on the Horizon Read More

Neuronetics, Inc

Neuronetics and Transformations Care Network Join Forces to Expand Availability of Innovative Depression Treatment

MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a leading name in the field of non-invasive treatments for mental health conditions, has announced a significant expansion of its commercial partnership with …

Neuronetics and Transformations Care Network Join Forces to Expand Availability of Innovative Depression Treatment Read More